NEW YORK (Reuters Health) – Patients with left ventricular (LV) dysfunction should receive human atrial natriuretic peptide (hANP) infusions during coronary artery bypass graft (CABG) surgery, Japanese researchers…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
NEW YORK (Reuters Health) – Patients on long-term stable warfarin therapy can safely be immunized against influenza, results of study from Italy indicate. In the study, influenza vaccination…
NEW YORK (Reuters Health) – Octogenarians with heart failure have a higher risk of in-hospital death after defibrillator or pacemaker placement, compared to younger patients, new research shows.…
NEW YORK (Reuters Health) – Adding omega-3 polyunsaturated fatty acids (PUFAs) to dual antiplatelet therapy after stent implantation boosts patients’ platelet response, investigators in Poland report. The P2Y12…
NEW YORK (Reuters Health) – Upgrading traditional 2 chamber cardiac pacemakers to modern 3 chamber pacemakers — cardiac resynchronization therapy (CRT) devices — improves left ventricular ejection fraction…
NEW YORK (Reuters Health) – Ambulatory telemetry can provide lifesaving information that is unavailable with other modalities, new research suggests. More than 26,000 patients with routine clinical indications…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – Patients starting clozapine must be monitored for endocarditis during the first month, particularly at week 3, new research shows. The researchers also suggest…